Literature DB >> 3623551

The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla.

A S Tischler, Y Dayal, K Balogh, R B Cohen, J L Connolly, K Tallberg.   

Abstract

Three adrenal medullary tumors that showed admixtures of pheochromocytomatous elements with ganglioneuroma or ganglioneuroblastoma were studied to determine the distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide (VIP). Two tumors consisted of typical pheochromocytoma cells admixed with mature-appearing ganglioneuroma. The third consisted of pheochromocytoma admixed with ganglioneuroblastoma and contained many immature and cytologically atypical cells. In all cases, chromogranin staining was absent or weak in neuronal perikarya and moderate to intense in varicosities of neuronal processes, a finding consistent with the presumed distribution of secretory granules in neurons. Chromogranin staining was also intense in chromaffin cells. Glial cells that stained for S-100 were randomly scattered among chromaffin cells but accumulated in areas with neuronal processes. Weak staining for VIP was present in neuronal cells in one of the two tumors with ganglioneuromatous features. Intense staining for VIP occurred in the third tumor in both neuronal and apparently nonneuronal cells. We conclude that granule distribution and cell-cell interactions for specific cell types in compound tumors tend to mimic those in normal adrenal medulla and sympathetic ganglia. Although immunoreactive VIP was localized exclusively to neurons in one tumor, as in normal tissues, patterns of staining for VIP across tumors are less predictable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623551     DOI: 10.1016/s0046-8177(87)80268-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Immunohistochemical identification and comparison of glial cell lineage in foetal, neonatal, adult and neoplastic human adrenal medulla.

Authors:  G Magro; S Grasso
Journal:  Histochem J       Date:  1997-04

Review 2.  Differential diagnosis of pheochromocytomas and paragangliomas.

Authors:  A M McNichol
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Immunohistochemical distribution of S-100 protein and type IV collagen in human embryonic and fetal sympathetic neuroblasts.

Authors:  G Magro; S Grasso; C Emmanuele
Journal:  Histochem J       Date:  1995-09

Review 4.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

5.  Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.

Authors:  James F Powers; Jaime M Brachold; Arthur S Tischler
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 6.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

7.  Characterization of Pheochromocytomas in a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis Gene Nf1.

Authors:  Arthur S. Tischler; T. Shane Shih; Bart O. Williams; Tyler Jacks
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

8.  Composite Pheochromocytoma-Ganglioneuroma of the Adrenal Gland: An Uncommon Entity with Distinctive Clinicopathologic Features.

Authors:  King-Yin Lam; Chung-Yau Lo
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

9.  Diverse proportion in composite pheochromocytoma-ganglioneuroma may induce varied clinical symptom: comparison of two cases.

Authors:  Bu-Yi Zhang; Mingfei Zhao; Baizhou Li; Jian-Min Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  The pathology of the adrenal glands in sudden infant death syndrome (SIDS)

Authors:  U Pérez-Platz; W Saeger; G Dhom; T Bajanowski
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.